Literature DB >> 15642392

TEL-AML1 frequency in multi-ethnic Malaysian pediatric acute lymphoblastic leukemia.

Harvindar Kaur Gill1, Ten Sew Keoh, Jasbir Singh Dhaliwal, Sarah Moore, Tan Sew Kim, Roshida Hassan, Faraiza Abdul Karim, Zubaidah Zakaria, Shahnaz Murad, Mahfuzah Mohamed, Caroline Mei Li Ho, Hishamshah Ibrahim, Eni Juraida Abdul Rahman.   

Abstract

Eighty-eight multi-ethnic Malaysian pediatric acute lymphoblastic leukemia (ALL) patients were screened for the TEL-AML1 rearrangement by reverse transcription-polymerase chain reaction (RT-PCR). Fluorescence in situ hybridization (FISH) was used as an independent screen for 30 cases and to confirm RT-PCR positive cases. Seventeen patients, or 19%, were found to be t(12;21) positive. Ethnically the group comprised 12 Malays, 4 Chinese, and 1 Indian. All patients, including 1 with an unusual blast cell morphology who suffered an early relapse and death, were characteristic TEL-AML1 cases in cell count, age, ALL subset classification, and fusion transcript expressed. This study shows that in Malaysia, TEL-AML1 is found in the same distinct ALL subset and at a similar frequency as in other diverse childhood ALL cohorts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642392     DOI: 10.1016/j.cancergencyto.2004.04.027

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  ETV6-RUNX1 Rearrangement in Tunisian Pediatric B-Lineage Acute Lymphoblastic Leukemia.

Authors:  Abir Gmidène; Hatem Elghezal; Hlima Sennana; Yosra Ben Youssef; Balkiss Meddeb; Moez Elloumi; Abderrahim Khlif; Ali Saad
Journal:  Adv Hematol       Date:  2009-12-22

2.  Chromosomal Aberrations in ETV6/RUNX1-positive Childhood Acute Lymphoblastic Leukemia using 244K Oligonucleotide Array Comparative Genomic Hybridization.

Authors:  Zubaidah Zakaria; Mohd Fadly Md Ahid; Azli Ismail; Ten Sew Keoh; Nooraisyah Mohamad Nor; Nor Rizan Kamaluddin; Ezalia Esa; Lam Kah Yuen; Eni Juraida Abdul Rahman; Raudhawati Osman
Journal:  Mol Cytogenet       Date:  2012-11-15       Impact factor: 2.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.